Cybin reports Q1 results

* Cybin press release [https://seekingalpha.com/pr/20200373-cybin-reports-important-progress-on-key-milestones-and-first-quarter-fiscal-year-2026] (NYSE:CYBN [https://seekingalpha.com/symbol/CYBN]): Q1 cash totaled $118.7 million as of June 30, 2025.
* Net loss was $24.6 million for the quarter ended June 30, 2025, compared to a net loss of $10.8 million in the same period last year.
* Cash-based operating expenses consisting of research, general, and administrative costs totaled $23.9 million for the quarter ended June 30, 2025, compared to $11.9 million, in the same period last year.
* Cash flows used in operating activities were $29.5 million for the quarter ended June 30, 2025, compared to $19.9 million in the same period last year.

MORE ON CYBIN 

* Cybin: Upgrade To Hold - But Don't Get Too Carried Away [https://seekingalpha.com/article/4800539-cybin-upgrade-to-hold-but-dont-get-too-carried-away]
* Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks [https://seekingalpha.com/news/4475753-psychedelic-stocks-up-abbvie-gilgamesh-deal-talks]
* Psychedelic medicine stocks fall following Compass depression asset data [https://seekingalpha.com/news/4461207-psychedelic-medicine-stocks-fall-following-compass-depression-asset-data]
* Seeking Alpha’s Quant Rating on Cybin  [https://seekingalpha.com/symbol/CYBN/ratings/quant-ratings]
* Historical earnings data for Cybin  [https://seekingalpha.com/symbol/CYBN/earnings]